Indian Earnings Mixed Amid Global Tech Jitters; NSDL Lock-in Expiry Looms

OTHER
Whalesbook Logo
Author Vihaan Mehta | Published at:
Indian Earnings Mixed Amid Global Tech Jitters; NSDL Lock-in Expiry Looms
Overview

India's benchmark indices are poised for a cautious start, influenced by Wall Street's tech-led decline and mixed signals from Asia. Domestically, Q3FY26 corporate results present a divergence: Tata Power's profits fall due to operational issues, while Emami and TMB post strong gains. A key event is the expiry of the lock-in period for 75% of NSDL's shares, potentially unlocking significant trading volume. This comes as many large-cap entities, including Bharti Airtel and LIC, are set to announce their earnings today.

The NSDL Lock-In Factor and Market Undercurrents

The Indian equity market faces a potentially volatile session on Thursday, February 5, 2026, as it navigates a dual set of influences: a global technology sector downturn and a significant domestic event. GIFT Nifty futures suggest a tepid opening, reflecting a cautious sentiment that has permeated Asian markets. South Korea's Kospi index notably fell, mirroring weakness in its semiconductor giants, while Wall Street indices closed mixed after a tech-driven sell-off on Wednesday. Investors are grappling with elevated valuations in the tech space, questioning the sustainability of recent AI-fueled rallies, which saw the Nasdaq Composite decline 1.51% and the S&P 500 slip 0.51%.

However, a unique domestic catalyst is the impending expiry of the six-month post-Initial Public Offering (IPO) lock-in period for National Securities Depository Limited (NSDL). Approximately 149.2 million shares, representing 75% of the depository's outstanding equity, will become eligible for trading today. This event could unlock substantial liquidity and potentially influence NSDL's share price dynamics significantly, though the broader market impact will depend on institutional investor positioning and overall sentiment.

Divergent Corporate Performance Amidst Operational Challenges

Quarterly earnings reports from Indian corporations reveal a mixed picture, highlighting operational resilience in some sectors and significant headwinds in others. Tata Power Company's net profit dropped 4% year-on-year to ₹1,194 crore for the third quarter of FY26, directly linked to the ongoing shutdown of its flagship Mundra thermal power plant in Gujarat, which also dragged revenue down 11%. This contrasts sharply with the performance of many other listed entities.

Global Health Limited, operating Medanta Hospitals, reported a substantial 33.5% year-on-year decline in net profit to ₹95.03 crore, yet its revenue from operations showed robust growth, rising 18% to ₹1,121 crore, indicating underlying demand for healthcare services. Similarly, Trent, the fashion and lifestyle retailer, posted a 3.1% rise in net profit alongside a 14.8% increase in revenue, demonstrating sustained consumer spending in its segment.

JSW Cement announced a striking turnaround, posting a net profit of ₹142 crore against a prior-year loss, supported by a 13.2% revenue increase. Emami, the FMCG firm, saw its net profit climb 14.5% driven by volume growth and margin expansion, while Tamilnad Mercantile Bank (TMB) achieved a record net profit of ₹342 crore, up 14% year-on-year, with its net interest income growing 13.28%.

Sectoral Trends and Strategic Maneuvers

Pharmaceuticals and diversified financial services also presented varied outcomes. Emcure Pharmaceuticals reported a strong 48% year-on-year rise in profit after tax (PAT) to ₹231 crore, fueled by double-digit growth across domestic and international markets. Bajaj Finserv's consolidated net profit remained flat at ₹2,229 crore, impacted by accelerated provisioning and a one-time charge related to new labor codes, a scenario not uncommon among NBFCs facing regulatory adjustments. Metropolis Healthcare, while showing 32% year-on-year net profit growth, experienced sequential declines in revenue and profit.

In strategic moves, Marico has agreed to acquire a 60% stake in Cosmix Wellness Private Limited, a digital-first functional wellness brand, signaling an expansion into the rapidly growing wellness sector. In the pharmaceutical space, Lupin announced the US FDA approval and launch of Topiramate Extended-Release Capsules, a move that could bolster its US market presence. Meanwhile, NHPC’s board approved the cancellation of an MoU for a joint venture solar power project in Odisha.

Outlook and Earnings Calendar

Today's earnings calendar is packed, with significant entities like Bharti Airtel, Life Insurance Corporation of India, Indian Oil Corporation, and Tata Motors Passenger Vehicles scheduled to release their Q3FY26 results. Investor focus will remain on the commentary regarding demand, input costs, and future outlook, especially against the backdrop of global economic uncertainties and sector-specific challenges. Analysts are closely watching the performance of consumer discretionary and select industrial names for signs of sustained economic activity, while pharmaceuticals continue to be a bright spot due to robust product pipelines and expanding market reach.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.